OVERVIEW
This 90-minute interactive symposium will feature a panel of experts evaluating the intricacies of care for patients with multiple myeloma through a series of challenging clinical cases. They will provide expert guidance and real-world perspectives related to optimizing outcomes at each phase of the treatment journey. Attendees can participate in interactive case challenges and engage directly with the expert panel in a closing Q&A session.
GOAL STATEMENT
The goal of this activity is for learners to be better able to interpret evidence for available and emerging therapies for MM and implement personalized treatment strategies into clinical practice.
LEARNING OBJECTIVES
Upon completion of this activity, participants will: Have increased knowledge regarding the[LIST][ITEM]Clinical trial data for MM therapies[ITEM]Factors that guide therapy selection[/LIST]Have greater competence related to[LIST][ITEM]Selecting therapy for the treatment of MM[/LIST]Demonstrate greater confidence in their ability to[LIST][ITEM]Personalize treatment for the management of MM[/LIST]
ACCREDITATION STATEMENT
In support of improving patient care, Medscape, LLC is jointly accredited with commendation by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. [JALOGO] [MEDSCAPE]
[bold]For Physicians[/bold] Medscape, LLC designates this live activity for a maximum of 1.5 [bold][italic]AMA PRA Category 1 Credits™[/italic][/bold]. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Marriott Marquis San Diego Marina
Grand Ballroom 5-6
333 W Harbor Dr Grand Ballroom 5-6
San Diego, California, 92101-7700
United States
Friday Satellite Symposium on Hematology/Oncology, preceding the 65th Annual Meeting and Exposition.
Supported by an independent educational grant from [bold]Bristol Myers Squibb, Janssen Biotech, Inc. administered by Janssen Scientific Affairs, LLC., Legend BioTech, Karyopharm, Sanofi[/bold].